Your session is about to expire
← Back to Search
Aminoglycoside Antibiotic
Gentamicin Sulfate for Urinary Tract Infection
Phase 2 & 3
Waitlist Available
Led By Denise Tate, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial looks at whether a medication can help reduce urinary infections and complications in people with spinal cord injuries, as well as improve their quality of life.
Eligible Conditions
- Urinary Tract Infection
- Spinal Cord Injury
- Spinal Cord Disease
- Neurogenic Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of urinary tract infections (UTI)
Secondary outcome measures
Neurogenic Urinary Bladder
Change in score of Neurogenic Bowel Dysfunction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Gentamicin sulfateExperimental Treatment1 Intervention
Participants initiate Gentamicin instillations every night for a period of 6 months. After baseline and consented they are instructed on how to do the instillations through a catheter, once they receive the drug and aid equipment (i.e. syringes) to do installations. Remaining drug is to be disposed after each use. Participants use their own catheters.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gentamicin Sulfate
2019
Completed Phase 3
~4410
Find a Location
Who is running the clinical trial?
Department of Health and Human ServicesFED
226 Previous Clinical Trials
928,936 Total Patients Enrolled
University of MichiganLead Sponsor
1,810 Previous Clinical Trials
6,385,092 Total Patients Enrolled
2 Trials studying Urinary Tract Infection
240 Patients Enrolled for Urinary Tract Infection
Denise Tate, PhDPrincipal Investigator - University of Michigan
University of Michigan
Share this study with friends
Copy Link
Messenger